DoW Breast Cancer, Breakthrough Award Level 3

US · MD Dept › of the Army -- USAMRAA (U › S › Army Medical Research Acquisition Activity) grant open #HT942526BCRPBTA3

Response due Sep 30, 2026 · 00:00 UTC

Summary

The Department of Defense (DoD), specifically the U.S. Army Medical Research Acquisition Activity (USAMRAA), is offering a Breakthrough Award Level 3 under the Department of Defense (DoW) Breast Cancer Research Program. This is a federal grant opportunity targeting high-impact, innovative breast cancer research. The award is intended to support groundbreaking scientific advances in the understanding, prevention, diagnosis, or treatment of breast cancer. Full programmatic details, eligibility, and application requirements are expected to be published in the full program announcement.

What they want

This opportunity is a grant funding mechanism under the DoD Breast Cancer Research Program (BCRP), Breakthrough Award Level 3. It is designed to support bold, innovative research with the potential to have a major impact on breast cancer. Level 3 awards represent the highest tier of the Breakthrough Award series, implying a larger funding scope and more transformative research expectations. Applicants are expected to address a critical breast cancer problem and demonstrate a clear path toward clinical or translational impact.

How they evaluate

Submission: Grants.gov federal grants portal (electronic submission)

Risks & flags

Extremely minimal synopsis — no scope details, eligibility criteria, or funding amount disclosed; full program announcement not yet available in source text
Single-line description with no substantive content may indicate an incomplete or placeholder posting

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541711

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

DoW Breast Cancer, Breakthrough Award Leve…

Due Sep 30

Onboard ↗